Business Context and Reporting Period
Company: BioLife Solutions, Inc. (BLFS)
Filing Type: Form 8-K (Current Report)
Report Date: March 3, 2025
Reporting Period: Fourth quarter and full year ended December 31, 2024
This filing serves as a notification that the company issued a press release containing financial results and operational highlights for the specified period. The detailed financial data is contained in Exhibit 99.1 (Press Release) attached to this filing.
Key Financial Metrics
The provided text for this Form 8-K does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being included in the attached press release (Exhibit 99.1) but are not present in the filing text itself.
Material Changes
The filing text does not provide specific details regarding material changes versus prior periods. It only confirms the announcement of results for the fourth quarter and year ended December 31, 2024.
Guidance, Outlook, and Risks
Management Commentary: The filing references operational highlights and financial results announced in the press release but does not include the text of that commentary.
Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Risks and Contingencies: No specific risks or contingencies are detailed in this filing text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual revenue, net income, and cash flow figures for Q4 and FY 2024.
- Verify year-over-year growth rates and margin trends in the attached press release.
- Check for any forward-looking guidance or updated financial outlook provided in the press release.
- Confirm the status of the company's debt obligations and liquidity position as detailed in the full financial statements.